Oderich Gustavo S, Malgor Rafael D, Ricotta Joseph J
Ann Vasc Surg. 2009 Sep-Oct;23(5):700-12. doi: 10.1016/j.avsg.2009.03.002. Epub 2009 Jun 21.
Chronic mesenteric ischemia is an uncommon disease in vascular surgery practice worldwide. Open revascularization remains the best treatment for low-risk patients due to durability and efficacy. Endovascular revascularization for chronic mesenteric ischemia was primarily indicated for elderly and higher-risk patients, but this has changed over the past 10 years due to development of more precise devices and lower morbidity and mortality rates despite the higher recurrence and restenosis rates. Our purpose was to summarize the data on endovascular and open revascularization for chronic mesenteric ischemia in a schematic tabular presentation.
慢性肠系膜缺血在全球血管外科实践中是一种罕见疾病。由于其耐久性和有效性,开放血管重建术仍然是低风险患者的最佳治疗方法。慢性肠系膜缺血的血管内血管重建术最初主要适用于老年和高风险患者,但在过去10年中,由于更精确设备的发展以及尽管复发和再狭窄率较高但发病率和死亡率较低,这种情况已经发生了变化。我们的目的是以示意性表格形式总结慢性肠系膜缺血的血管内和开放血管重建术的数据。